STASIS
NDC 10129-031, Ferric Sulfate, solution, from Gingi-Pak a Division of the Belport.
- Product NDC
- 10129-031
- Status
- Listed
- Labeler
- Gingi-Pak a Division of the Belport
- Dosage form
- SOLUTION
- Route
- DENTAL, PERIODONTAL, SUBGINGIVAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- UNAPPROVED DRUG OTHER
- Application
- —
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/10129-031 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- FERRIC SULFATE3150 mg/15mL
Pharmacologic classes
Iron [CS]; Parenteral Iron Replacement [EPC]; Phosphate Binder [EPC]; Phosphate Chelating Activity [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 10129-031-01 | 10129003101 | 15 mL in 1 BOTTLE, GLASS (10129-031-01) |
| 10129-031-02 | 10129003102 | 40 mL in 1 BOTTLE, GLASS (10129-031-02) |
Linked data
RxNorm, label and prices
RxNorm concepts
RxNorm links no concept to this product's packages.
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 10129-031 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/10129-031 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 10129-031. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.